Caredx Inc [CDNA] stock is trading at $14.77, down -1.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CDNA shares have gain 1.79% over the last week, with a monthly amount drifted -2.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wells Fargo upgraded its rating to Equal Weight on January 15, 2025, and dropped its price target to $24. On August 28, 2024, Wells Fargo initiated with a Underweight rating and assigned a price target of $28 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $40 on August 19, 2024. Raymond James downgraded its rating to a Mkt Perform. Craig Hallum upgraded its rating to Buy for this stock on May 01, 2024, but kept the price target unchanged to $15. In a note dated November 09, 2023, Stephens upgraded an Overweight rating on this stock but restated the target price of $10.
Caredx Inc [CDNA] stock has fluctuated between $10.96 and $26.37 over the past year. Currently, Wall Street analysts expect the stock to reach $28.8 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $14.77 at the most recent close of the market. An investor can expect a potential return of 94.99% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Caredx Inc [NASDAQ:CDNA] reported sales of 340.83M for the trailing twelve months, which represents a drop of -6.06%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.15 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.36 points at the first support level, and at 13.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.23, and for the 2nd resistance point, it is at 15.70.
Ratios To Look Out For
For context, Caredx Inc’s Current Ratio is 3.30. In addition, the Quick Ratio stands at 3.00 and the Cash Ratio stands at 0.73. Considering the valuation of this stock, the price to sales ratio is 2.31, the price to book ratio is 2.40 and price to earnings (TTM) ratio is 14.46.
Transactions by insiders
Recent insider trading involved ABHISHEK JAIN, Officer, that happened on Oct 31 ’25 when 9964.0 shares were purchased. Secretary and General Counsel, Novack Jeffrey Adam completed a deal on Aug 05 ’25 to sell 2688.0 shares. Meanwhile, Officer Jeffrey Adam Novack bought 2688.0 shares on Aug 05 ’25.
